Outcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysis

Authors :: S Parthiban
Raajit Chanana
Sanjeev Kumar
Sujay Srinivas
G.S. Grewal
N. Rathnasamy
Alok Goel
K. Gupta
J. Bajpai
Dilip Harindran Vallathol
Source :: Annals of Oncology. 29:ix128
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Soft tissue sarcoma
Hematology
medicine.disease
Second line chemotherapy
Gemcitabine
Docetaxel
Internal medicine
medicine
Retrospective analysis
In patient
business
medicine.drug

Full Text Access

Tools